Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleTHE FIRST‐IN‐CLASS ETS INHIBITOR TK‐216 INTERFERES WITH ETS TRANSCRIPTION FACTORS AND SYNERGIZE WITH LENALIDOMIDE IN LYMPHOMA.AuthorsSpriano, F.; Chung, E.; Napoli, S.; Tarantelli, C.; Gaudio, E.; Cascione, L.; Cavalli, A.; Rinaldi, A.; Kwee, I.; Ye, H.; Rossi, D.; Zucca, E.; Stathis, A.; Jessen, K.; Lannutti, B.; Toretsky, J.; Bertoni, F.SubjectsTRANSCRIPTION factors; ANAPLASTIC lymphoma kinase; RNA helicase; CHIMERIC proteins; GENE expression profilingPublicationHematological Oncology, 2019, Vol 37, p322ISSN0278-0232Publication typeArticleDOI10.1002/hon.132_2630